GBT021601-012

GBT021601-012 · Global Blood Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GBT021601-012, covering 2024-06-10 to 2024-06-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate GBT021601-012 Single Dose and Multiple Dose in Participants With Sickle Cell Disease (SCD) [Phase 1]

See pricing